Options
Associations between LncRNA MALAT1 Polymorphisms and Lymph Node Metastasis in Prostate Cancer
Journal
Diagnostics
Journal Volume
11
Journal Issue
9
Start Page
1692
ISSN
2075-4418
Date Issued
2021-09-16
Author(s)
Ju-Chuan Hu
Shian-Shiang Wang
Kun-Yuan Chiu
Jian-Ri Li
Chuan-Shu Chen
Sheng-Chun Hung
Cheng-Kuang Yang
Yen-Chuan Ou
Chen-Li Cheng
Chia-Yen Lin
Abstract
<jats:p>Current evidence elucidates that long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) could regulate genetic expression and play a crucial role in both the diagnosis and prognosis of prostate cancer. Single-nucleotide polymorphisms (SNPs) of MALAT1 could alter the oncogenesis in various cancers. However, the associations between MALAT1 SNPs and prostate cancer have barely been investigated to date. This study included 579 patients with prostate cancer who received robotic-assisted radical prostatectomy at Taichung Veterans General Hospital from 2012 to 2017. Three SNPs of MALAT1 were analyzed to identify the impacts of SNPs on the clinicopathologic features in Taiwanese prostate cancer. Our results show that patients with a polymorphic G allele at rs619586 had a significantly higher risk of being in an advanced Gleason grade group (AOR: 1.764; 95% CI: 1.011–3.077; p = 0.046). Moreover, individuals with at least one polymorphic A allele at MALAT1 rs1194338 in the PSA >10 ng/mL group were positively associated with node-positive prostate cancer. In conclusion, MALAT1 SNPs are significantly associated with the susceptibility to both advanced Gleason grade and nodal metastasis in prostate cancer. The presence of MALAT1 SNPs rs619586 and rs1194338 seems to enhance oncogenesis in prostate cancer.</jats:p>
SDGs
Publisher
MDPI AG
Type
journal-article